r.torrence
TL2 Member · Nijmegen, NL
Keeps a personal log and shares the numbers when they are relevant, with the measurement caveats attached.
Joined 16 August 2025 · last posted 3d
68 posts, newest first. Showing up to 150.
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #35 · Compounds › Semaglutide · 25 Jul 2026 · 13 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
GIP receptor agonism and the argument about direction — does this still hold? Replied, post #14 · Pharmacology › Receptor biology · 25 Jul 2026 · 4 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #72 · Start Here › Welcome · 22 Jul 2026 · 25 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Documenting a supplier's response to a discrepancy Replied, post #39 · Sourcing › Vendor reports · 15 Jul 2026 · 3 likes I read post #37 twice before replying, because I had assumed the opposite. Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #28 · Practice › Dosing & titration · 30 Jun 2026 · 16 likes On post #24 — agreed on the reasoning, with one qualification. How the published trials escalated: they used specific step sizes and intervals. The STEP programme used…
-
Why the timeline is on the right and not the left — what changed since Replied, post #64 · Meta › Site feedback · 29 Jun 2026 · 6 likes Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth reporting with details (when, which pages, how slow).
-
GLP-1 receptor distribution: central and peripheral Replied, post #78 · Pharmacology › Receptor biology · 27 Jun 2026 · 0 likes Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #41 · Compounds › Secretagogues & GH axis · 19 Jun 2026 · 0 likes This follows post #38 rather than contradicting it. Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with…
-
Submitting a sample: the process end to end Replied, post #12 · Sourcing › Independent verification · 11 Jun 2026 · 12 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #20 · Practice › Administration · 9 Jun 2026 · 23 likes On post #16 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Official shortage notices and what they authorise Replied, post #93 · Access › Shortages · 7 Jun 2026 · 1 like Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #95 · Sourcing › Red flags · 6 Jun 2026 · 0 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
-
What a certificate commits its issuer to — one year on Replied, post #77 · Analytics › COA interpretation · 28 May 2026 · 18 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #84 · Outcomes › Body composition · 27 May 2026 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
How this community labels and discusses unrefereed work — the long version Replied, post #7 · Evidence › Preprints · 11 May 2026 · 5 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #21 · Analytics › HPLC & UHPLC · 3 May 2026 · 25 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #92 · Compounds › Tirzepatide · 21 Apr 2026 · 0 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Amylin receptor signalling and satiety — what changed since Replied, post #58 · Pharmacology › Receptor biology · 8 Apr 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
EU-wide position versus national implementation — what changed since Replied, post #22 · Regional › European Union · 5 Apr 2026 · 1 like post #21 answers the question as asked. The question underneath it is different. Reimbursement varies substantially by member state. Some (Germany, France, Netherlands)…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #79 · Analytics › Mass spectrometry · 23 Mar 2026 · 19 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Revisiting: Absolute versus relative contraindications Replied, post #48 · Safety › Contraindications · 21 Mar 2026 · 18 likes This follows post #45 rather than contradicting it. Severe renal impairment (eGFR
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #76 · Compounds › Cagrilintide & amylin analogues · 19 Mar 2026 · 0 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
-
Guidelines revision: what changed and why — one year on Replied, post #76 · Meta › Announcements · 28 Feb 2026 · 0 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #123 · Practice › Dosing & titration · 21 Feb 2026 · 20 likes post #122 is right about the mechanism and I think understates the practical bit. How the published trials escalated: they used specific step sizes and intervals. The…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #16 · Analytics › COA interpretation · 8 Feb 2026 · 1 like Coming back to post #14, because the follow-up matters more than the original answer. When method identifiers are missing: "reversed-phase HPLC" is less specific than…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #20 · Practice › Storage & stability · 17 Jan 2026 · 0 likes post #19 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #39 · Practice › Storage & stability · 21 Dec 2025 · 19 likes post #38 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #61 · Compounds › Tirzepatide · 9 Dec 2025 · 12 likes post #60 is right about the mechanism and I think understates the practical bit. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at…
-
Heterogeneity as information rather than as a nuisance Replied, post #10 · Evidence › Meta-analyses · 28 Nov 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #69 · Compounds › Tirzepatide · 22 Oct 2025 · 12 likes Picking up post #66: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Research-use-only status: what it means legally and practically — does this still hold? Replied, post #3 · Compounds › Other compounds · 21 Oct 2025 · 0 likes post #2 is right about the mechanism and I think understates the practical bit. Distinguishing marketed research compounds from true chemical synthesis: some online…
-
New subcategory: rationale and scope Replied, post #36 · Meta › Announcements · 16 Oct 2025 · 7 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning.
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #13 · Start Here › Welcome · 12 Oct 2025 · 12 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #11 · Research Methods › N-of-1 designs · 12 Oct 2025 · 3 likes Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to…
-
Sleep quality changes during weight loss — what changed since Replied, post #14 · Wellbeing › Sleep · 1 Oct 2025 · 17 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Which panel is worth repeating and which is worth ignoring Replied, post #125 · Clinical › Bloodwork · 30 Sep 2025 · 7 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Pages past their review date, listed Replied, post #24 · Meta › Wiki maintenance · 30 Aug 2025 · 14 likes This follows post #21 rather than contradicting it. Review dates: each maintained page has a review date (the date by which it should be checked). If a page is past its…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #10 · Lounge › Off topic · 28 Aug 2025 · 2 likes Worth separating two things that post #6 runs together. Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #74 · Evidence › Journal club · 20 Aug 2025 · 9 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
A request that was declined, and the reasoning — a second dataset Replied, post #99 · Documentation › Wiki requests · 16 Aug 2025 · 0 likes post #98 answers the question as asked. The question underneath it is different. Correction requests: if you spot an error in a maintained page, note it here with the…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #41 · Compounds › Semaglutide · 13 Aug 2025 · 0 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Gauge and length selection for subcutaneous injection Replied, post #16 · Devices › Syringes & needles · 30 Jul 2025 · 3 likes On post #12 — agreed on the reasoning, with one qualification. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #37 · Sourcing › Regulatory · 29 Jun 2025 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #20 · Compounds › Semaglutide · 29 Jun 2025 · 7 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Excipient function in a licensed injectable Replied, post #8 · Pharmacology › Formulation chemistry · 31 May 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Started this topic · Pharmacology › Receptor biology · 18 May 2025 · 27 likes Revisiting: GLP-1 receptor distribution: central and peripheral — setting out what I have, and where I think it stops being reliable. A documentation question rather…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #4 · Start Here › How to Ask · 18 May 2025 · 12 likes Worth separating two things that the opening post runs together. Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post,…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #121 · Compounds › Semaglutide · 17 May 2025 · 0 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
Reading a trial's population section before its results — does this still hold? Replied, post #70 · Evidence › Trials · 5 May 2025 · 16 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #123 · Evidence › Journal club · 22 Apr 2025 · 23 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #60 · Practice › Reconstitution · 21 Apr 2025 · 17 likes Worth separating two things that post #56 runs together. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe…
-
A well-designed study with a badly written abstract Replied, post #28 · Evidence › Study critique · 17 Apr 2025 · 9 likes Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not…
-
UK access routes, dated and sourced — a second dataset Replied, post #64 · Regional › UK & Ireland · 15 Apr 2025 · 2 likes On post #60 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #73 · Compounds › Semaglutide · 11 Apr 2025 · 31 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Antibiotics and a course of something with delayed emptying Replied, post #17 · Practice › Interactions · 8 Apr 2025 · 15 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #21 · Evidence › Trials · 29 Mar 2025 · 23 likes I read post #19 twice before replying, because I had assumed the opposite. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation…
-
Maintainer handover: how it works Replied, post #63 · Meta › Wiki maintenance · 18 Mar 2025 · 5 likes Picking up post #60: that is the part I would want checked first. Revision disputes: if you disagree with an edit a maintainer made, discussing it here invites…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #19 · Compounds › Secretagogues & GH axis · 4 Mar 2025 · 0 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
A supplier that answers analytical questions with restated claims Replied, post #31 · Sourcing › Red flags · 27 Feb 2025 · 29 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
Consistent declarations and why they matter more than clever ones Replied, post #59 · Sourcing › Logistics · 20 Feb 2025 · 1 like Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Coming back to: Renal impairment: what the labelling says about dose Replied, post #29 · Clinical › Special populations · 14 Jan 2025 · 0 likes I read post #27 twice before replying, because I had assumed the opposite. Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #47 · Practice › Interactions · 10 Jan 2025 · 16 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #3 · Sourcing › Vendor reports · 1 Jan 2025 · 1 like I read the opening post twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #26 · Practice › Side effects · 26 Nov 2024 · 3 likes post #25 is right about the mechanism and I think understates the practical bit. Pancreatitis: a rare but serious event with a specific presentation (epigastric pain,…
-
Food noise reducing and the disorientation that can follow Replied, post #27 · Wellbeing › Mental health · 23 Oct 2024 · 23 likes Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and anxiety. Addressing sleep separately from mood matters.
-
Transit times by route, from a logged dataset — the long version Replied, post #7 · Sourcing › Logistics · 23 Aug 2024 · 16 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
-
Identical chromatograms across two different lots Replied, post #12 · Sourcing › Red flags · 6 Aug 2024 · 0 likes Worth separating two things that post #8 runs together. Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin…
-
How this community labels and discusses unrefereed work Replied, post #120 · Evidence › Preprints · 28 Jul 2024 · 12 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…